S'abonner

The common variable immunodeficiency IgM repertoire narrowly recognizes erythrocyte and platelet glycans - 25/05/24

Doi : 10.1016/j.jaci.2024.04.018 
Carole Le Coz, PhD a, b, Melissa Trofa, MD a, Dorothy L. Butler, PhD c, Samuel Yoon, BS a, Tian Tian, PhD d, Whitney Reid, MD a, Emylette Cruz Cabrera, MS a, Ainsley V.C. Knox, BA a, Caroline Khanna, MD a, Kathleen E. Sullivan, MD, PhD a, e, f, Jennifer Heimall, MD a, e, Patricia Takach, MD g, Olajumoke O. Fadugba, MD g, Monica Lawrence, MD h, Soma Jyonouchi, MD a, e, Hakon Hakonarson, MD, PhD d, f, Andrew D. Wells, PhD f, i, j, Steven Handler, MD, MBE k, l, Karen B. Zur, MD k, l, Vinodh Pillai, MD, PhD m, n, Jeffrey C. Gildersleeve, PhD c, Neil Romberg, MD a, e, f,
a Division of Immunology and Allergy, Children’s Hospital of Philadelphia, Philadelphia, Pa 
b Infinity, Toulouse Institute for Infectious and Inflammatory Diseases, University of Toulouse, CNRS, Inserm, Toulouse, France 
c Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Md 
d Center for Applied Genomics, Children’s Hospital of Philadelphia, Philadelphia, Pa 
e Department of Pediatrics, Perelman School of Medicine, Philadelphia, Pa 
f Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa 
g Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Perelman School of Medicine, Philadelphia, Pa 
h Division of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia, Charlottesville, Va 
i Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, Pa 
j Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pa 
k Pediatric Otolaryngology, Children’s Hospital of Philadelphia, Philadelphia, Pa 
l Department of Otolaryngology—Head and Neck Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pa 
m Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pa 
n Division of Hematopathology, Children’s Hospital of Philadelphia, Philadelphia, Pa 

Corresponding author: Neil Romberg, MD, Division of Immunology and Allergy, Children’s Hospital of Philadelphia, Abramson Research Center, Philadelphia, PA 19104.Division of Immunology and AllergyChildren’s Hospital of PhiladelphiaAbramson Research CenterPhiladelphiaPA19104
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Saturday 25 May 2024
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Background

Autoimmune cytopenias (AICs) regularly occur in profoundly IgG-deficient patients with common variable immunodeficiency (CVID). The isotypes, antigenic targets, and origin(s) of their disease-causing autoantibodies are unclear.

Objective

We sought to determine reactivity, clonality, and provenance of AIC-associated IgM autoantibodies in patients with CVID.

Methods

We used glycan arrays, patient erythrocytes, and platelets to determine targets of CVID IgM autoantibodies. Glycan-binding profiles were used to identify autoreactive clones across B-cell subsets, specifically circulating marginal zone (MZ) B cells, for sorting and IGH sequencing. The locations, transcriptomes, and responses of tonsillar MZ B cells to different TH- cell subsets were determined by confocal microscopy, RNA-sequencing, and cocultures, respectively.

Results

Autoreactive IgM coated erythrocytes and platelets from many CVID patients with AICs (CVID+AIC). On glycan arrays, CVID+AIC plasma IgM narrowly recognized erythrocytic i antigens and platelet i-related antigens and failed to bind hundreds of pathogen- and tumor-associated carbohydrates. Polyclonal i antigen–recognizing B-cell receptors were highly enriched among CVID+AIC circulating MZ B cells. Within tonsillar tissues, MZ B cells secreted copious IgM when activated by the combination of IL-10 and IL-21 or when cultured with IL-10/IL-21–secreting FOXP3CD25hi T follicular helper (Tfh) cells. In lymph nodes from immunocompetent controls, MZ B cells, plentiful FOXP3+ regulatory T cells, and rare FOXP3CD25+ cells that represented likely CD25hi Tfh cells all localized outside of germinal centers. In CVID+AIC lymph nodes, cellular positions were similar but CD25hi Tfh cells greatly outnumbered regulatory cells.

Conclusions

Our findings indicate that glycan-reactive IgM autoantibodies produced outside of germinal centers may contribute to the autoimmune pathogenesis of CVID.

Le texte complet de cet article est disponible en PDF.

Key words : Common variable immune deficiency, autoimmune cytopenias, autoantibodies, glycans, i antigen, marginal zone B cell

Abbreviations used : AIC, AIHA, APC, CDR, CVID, ES, FACS, FITC, GC, HD, IRB, iTfr, ITP, IVIG, LacNAc, LNnO, MNC, MZ, PBST, PMT, RFU, RNA-seq, Tfh, Tfr, TLR, Treg


Plan


© 2024  American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.